It's 'biology's century,' but are we prepared?; new CDC opioid guidelines emphasize flexibility in treating pain

From CRISPR to gene therapy, the biggest looming problem is that we will simply become lost and confused as to what works and what doesn't. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by      Here's why we're not prepared for the next wave of biotech innovation By Matthew Herper From CRISPR to gene therapy, the biggest looming problem is that we will simply become lost and confused as to what works and what doesn't. Read More New CDC opioid guidelines emphasize flexibility in treating pain By Andrew Joseph Patrick Sison/AP The CDC drops some recommendations that had been interpreted too strictly, leaving some patients with uncontrolled pain. Read More Telehealth startups prescribing ketamine at home are stirring concern By Katie Palmer COLE BURSTON/AFP via Getty Images Venture capital investment in at-home ketamine startups surged during the pandemic. But the new crop of businesses is stirring concern. Read More Sponsored Insight by HEALTHCARE DISTRIBUTION ALLIANCE How do healthcare distributors support 20,000 independent pharmacies across the country? Distributors provide logistics expertise and administrative services, helping independent pharmacists navigate change, optimize business performance, implement the latest technologies and learn about new industry trends. Through Pharmacy Services Administrative Organizations (PSAOs), healthcare distributors amplify the voices of independent pharmacists to interact with healthcare insurers and PBMs, ultimately creating administrative efficiencies for these small businesses. Learn more about the critical services that enable pharmacists to better focus on patient care and serve their communities. STAT+: A leaked version of a U.K.-India free trade deal sparks alarm over access to medicines By Ed Silverman Adobe There is concern the proposed deal would impede the supply of affordable generic medicines in poor countries around the world. Read More When it comes to caring for underserved patients, health tech is still figuring out what success looks like By Mohana Ravindranath Adobe Health tech companies claim they can improve care for underserved patients. But there's no standard way to measure success. Read More Opinion: STAT+: HHS's proposed rule prohibiting discrimination via algorithm needs strengthening By Ashley Beecy and Steve Miff and Karandeep Singh Adobe Lax language and loopholes could thwart HHS's proposed rule to prohibit clinical algorithms from discriminating against individuals. Read More Providers of methadone treatment say a big increase in access could backfire By Lev Facher Laura Morton for STAT Opponents of expanded access argue that counseling and other services must accompany methadone treatment. Proponents say it's an emergency. Read More Opinion: How the world can end Covid-19 as a public health threat By Jeffrey V. Lazarus and Adeeba Kamarulzaman and Agnes Binagwaho Adobe 400 experts from 100 countries created consensus recommendations to achieve changes needed to end Covid-19 as a public health threat. Read More Listen: How the biotech revolution could come apart at the seams By Damian Garde and Allison DeAngelis and Adam Feuerstein STAT's Matthew Herper joins us to discuss his story on how the biotech revolution could run aground if humanity can't get out of its own way. Read More Thursday, November 3, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser